Defined Protein Modification SitesControlled Loading and Linker DesignResearch-Ready Protein Conjugates
BOC Sciences provides site-specific protein conjugation services for research teams developing defined conjugates from recombinant proteins, enzymes, binding proteins, protein domains, and other engineered biomolecules. Projects can support fluorescent labels, biotin, PEG, peptides, oligonucleotides, small molecules, linkers, and other functional payloads.
We assess protein sequence and structure, accessible residues, engineered handles, terminal sites, enzymatic recognition motifs, payload chemistry, desired loading, purification, and downstream assay requirements before selecting a route. Services can connect with protein conjugation services, protein oligonucleotide conjugation, and enzymatic bioconjugation services.
Protein conjugation can become difficult when multiple reactive residues are available, a functional domain is sensitive to modification, or the payload changes protein solubility and aggregation behavior. Site-specific approaches use defined cysteines, engineered amino acids, terminal residues, peptide tags, enzymatic recognition sites, or orthogonal handles to restrict the modification pathway.
A useful development strategy connects site accessibility with reaction chemistry, linker architecture, payload properties, purification, and analytical verification. This makes it easier to compare conjugates on structure, loading, stability, and function rather than evaluating coupling conversion alone.

Technical illustration of site-specific protein conjugation services, highlighting the relationship between site selection, conjugation chemistry, and functional payload attachment.
Modification near an active site, binding interface, oligomerization region, or structural element can change protein behavior. Site placement and linker geometry are evaluated against the protein architecture.
A residue that is chemically available in the sequence may be buried or conformationally restricted. Structural context and reaction conditions influence whether the selected site is practically addressable.
Higher loading is not necessarily better for every protein. Payload density can affect aggregation, solubility, folding, and assay behavior, so loading targets are linked to the intended research use.
Free payload, unmodified protein, aggregates, and positional variants can require different analytical approaches. Purification and characterization are planned together with the conjugation route.
We provide custom development from route selection and reaction planning through conjugation, purification, and analytical characterization. Project scope can be configured around customer-supplied biomolecules, functionalized payloads, engineered constructs, or an existing method requiring optimization.
Capabilities include:
Typical applications:
Protein labeling, PEGylation, fluorescent probes, and defined payload attachment.
Capabilities include:
Typical applications:
Structure–function studies, protein probes, and controlled functionalization.
Capabilities include:
Typical applications:
Protein labeling, modular conjugates, and site-selective modification.
Capabilities include:
Typical applications:
Protein–oligonucleotide, protein–peptide, imaging, and multifunctional conjugates.
Site-specific conjugation performance depends on the relationship between the biomolecule, accessible attachment site, reaction chemistry, linker and payload, loading target, and downstream analytical requirements. The table below summarizes the variables that most often influence development decisions.
| Design Parameter | Common Options | Development Considerations | Impact on Conjugate Performance | Why It Matters to Customers |
| Protein Format | Recombinant protein, enzyme, binding protein, domain, engineered protein | Size, oligomeric state, sequence, and structural stability affect site selection. | Determines accessible regions and compatibility with reaction conditions. | Prevents a generic chemistry from being applied without regard to protein architecture. |
| Reactive Site | Cysteine, engineered residue, terminal site, peptide tag, enzymatic motif, bioorthogonal handle | Accessibility and distance from functional regions should be considered. | Influences site selectivity, loading, and functional retention. | Helps define a reproducible modification strategy. |
| Payload and Linker | Fluorophore, biotin, PEG, peptide, oligonucleotide, small molecule, polymer | Size, charge, hydrophobicity, and reactive groups affect coupling and purification. | Can change solubility, aggregation, and assay behavior. | Connects payload selection with conjugate performance. |
| Loading Target | Single-site, controlled low loading, multi-site loading | Target loading should reflect the application rather than maximize reaction conversion. | Affects product composition and biological or assay response. | Provides a practical development criterion. |
| Reaction Environment | Buffer, pH, temperature, equivalents, reaction time, redox state | Protein stability and reactive-group chemistry must be maintained together. | Controls conversion and side reactions. | Supports reproducible development. |
| Purification and Analytics | SEC, HPLC, LC-MS, peptide mapping, electrophoresis, functional assays | Method choice depends on protein size, conjugate architecture, and development question. | Assesses free payload, aggregates, modification, and integrity. | Provides evidence for selecting and reproducing a preferred construct. |
Method selection should be driven by biomolecule architecture, site accessibility, reactive-group compatibility, payload properties, desired loading, and the analytical evidence needed to verify the final construct. Different routes can be compared when a single chemistry does not adequately balance selectivity, stability, and product quality.
| Conjugation Strategy | Technical Approach | Common Applications | Development Advantages |
| Cysteine-Directed Conjugation | Cysteine thiols are reacted with compatible thiol-selective reagents. | Protein labels, PEG conjugates, and functional payloads | Provides a direct route when a suitable cysteine site is available. |
| Engineered Residue Conjugation | An introduced residue or chemical handle provides a predetermined reaction site. | Defined protein conjugates and structure–function studies | Can improve positional control when the engineered construct is compatible. |
| Enzymatic Conjugation | An enzyme recognizes a sequence or motif to install or couple a functional group. | Protein labeling and modular conjugates | Can provide selective modification without relying solely on side-chain reactivity. |
| Terminal Conjugation | N- or C-terminal functional groups are used for attachment when compatible with protein architecture. | Protein labeling and controlled functionalization | Can place modification away from internal residues when the terminal site is suitable. |
| Bioorthogonal Coupling | Orthogonal handles are installed and coupled using compatible click chemistry. | Multicomponent and multifunctional protein conjugates | Enables modular assembly and broad payload compatibility. |
Analytical characterization is used to establish whether the intended modification occurred and whether the resulting conjugate has the purity, loading, structural integrity, and functional properties needed for the research objective. Orthogonal methods are selected according to construct and development stage.
| Analytical Category | Methodology | Purpose in Development | Data Delivered |
| Modification Site | LC-MS/MS, peptide mapping, intact-mass analysis | Confirm the location or distribution of the modification where analytically feasible. | Site-assignment and comparative modification data. |
| Loading | LC-MS, HPLC, UV-Vis, or other suitable methods | Estimate conjugation level and compare reaction conditions. | Loading summary and batch comparison. |
| Purity and Aggregation | SEC-HPLC, HPLC, electrophoresis, or other suitable methods | Assess product distribution and aggregation. | Chromatographic and purity observations. |
| Protein Integrity | Intact mass, spectroscopy, electrophoresis, or application-specific methods | Monitor structural consistency after modification. | Integrity data and comparative profiles. |
| Functional Performance | Binding, enzymatic activity, capture, or other application-relevant assay | Determine whether conjugation preserves the function required by the study. | Comparative functional results. |
Project workflow: strategy selection, site-specific conjugation, purification, analytical characterization, and delivery of the resulting research conjugate and data package.
Define protein format, available sites, payload, loading target, and intended application.

Compare residue-directed, engineered, enzymatic, terminal, or bioorthogonal approaches.

Run the selected coupling route and remove unreacted components and unsuitable product species.

Assess modification, loading, purity, aggregation, integrity, and application-relevant function.

Provide the research conjugate with analytical results and relevant process information.

Conjugation chemistry is selected in the context of protein structure, accessibility, stability, and functional regions.


Reaction optimization is linked with purification and characterization so product quality is considered throughout the workflow.

Analytical methods are selected around the actual development question, including site, loading, integrity, aggregation, and function.

Projects can be built around recombinant proteins, enzymes, engineered constructs, and other compatible biomolecule formats.
Whether you need a defined protein label, enzyme conjugate, protein–oligonucleotide construct, or another functional protein conjugate, we support route selection, conjugation, purification, and characterization.
Share your protein format, available modification sites, payload or linker, desired loading, and application with our scientific team. Contact our scientific team to discuss your site-specific protein conjugation requirements.
Recombinant proteins, enzymes, binding proteins, protein domains, and engineered constructs can be considered when their structure and available handles support the selected chemistry.
Not always. Native cysteine, terminal, glycan, or enzymatic strategies may be possible, while some highly defined approaches require an engineered handle.
Site selection considers solvent accessibility, distance from functional regions, residue uniqueness, structural tolerance, desired orientation, and analytical confirmation.
Yes. Purification can be selected according to protein size, payload, aggregation tendency, and the presence of free reagents or byproducts.
Yes. Protein–oligonucleotide conjugation can use defined handles and compatible linkers when the protein and oligonucleotide are chemically suitable.
